ロード中...
Low-dose ruxolitinib for improving leukopaenia and reducing recurrent infections associated with myelofibrosis
Myelofibrosis, either primary or resulting from essential thrombocythemia or polycythemia vera, may present with highly variable white blood cell counts, including progressive leukopaenia with its associated risk of infections. Medications have been developed to reduce splenomegaly and other symptom...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3670020/ https://ncbi.nlm.nih.gov/pubmed/23704469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2013-010068 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|